We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Intermune Eyes Settlement Over Off-Label Marketing

Law360 (July 28, 2006, 12:00 AM EDT) -- Biotechnology company Intermune Inc. is preparing to pay as much as $30 million to settle allegations from federal prosecutors that it illegally promoted a drug for a use not approved by...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.